159 related articles for article (PubMed ID: 28410303)
1. Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy.
Yee C; Lizee GA
Cancer J; 2017; 23(2):144-148. PubMed ID: 28410303
[TBL] [Abstract][Full Text] [Related]
2. Adoptive cell transfer as personalized immunotherapy for human cancer.
Rosenberg SA; Restifo NP
Science; 2015 Apr; 348(6230):62-8. PubMed ID: 25838374
[TBL] [Abstract][Full Text] [Related]
3. Endogenous T-Cell Therapy: Clinical Experience.
Yee C; Lizee G; Schueneman AJ
Cancer J; 2015; 21(6):492-500. PubMed ID: 26588682
[TBL] [Abstract][Full Text] [Related]
4. Adoptive Cellular Therapy (ACT) for Cancer Treatment.
Yang F; Jin H; Wang J; Sun Q; Yan C; Wei F; Ren X
Adv Exp Med Biol; 2016; 909():169-239. PubMed ID: 27240459
[TBL] [Abstract][Full Text] [Related]
5. Adoptive therapy using antigen-specific T-cell clones.
Yee C
Cancer J; 2010; 16(4):367-73. PubMed ID: 20693849
[TBL] [Abstract][Full Text] [Related]
6. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
[TBL] [Abstract][Full Text] [Related]
7. Adoptive T-cell immunotherapy of cancer.
Li Q; Chang AE
Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
[TBL] [Abstract][Full Text] [Related]
8. Adoptive cell therapy: past, present and future.
Cohen JE; Merims S; Frank S; Engelstein R; Peretz T; Lotem M
Immunotherapy; 2017 Jan; 9(2):183-196. PubMed ID: 28128715
[TBL] [Abstract][Full Text] [Related]
9. Adoptive-cell-transfer therapy for the treatment of patients with cancer.
Dudley ME; Rosenberg SA
Nat Rev Cancer; 2003 Sep; 3(9):666-75. PubMed ID: 12951585
[TBL] [Abstract][Full Text] [Related]
10. Antigen choice in adoptive T-cell therapy of cancer.
Offringa R
Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB-based isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapy.
Choi BK; Lee SC; Lee MJ; Kim YH; Kim YW; Ryu KW; Lee JH; Shin SM; Lee SH; Suzuki S; Oh HS; Kim CH; Lee DG; Hwang SH; Yu EM; Lee IO; Kwon BS
J Immunother; 2014 May; 37(4):225-36. PubMed ID: 24714356
[TBL] [Abstract][Full Text] [Related]
12. Use of high throughput qPCR screening to rapidly clone low frequency tumour specific T-cells from peripheral blood for adoptive immunotherapy.
Kammula US; Serrano OK
J Transl Med; 2008 Oct; 6():60. PubMed ID: 18937837
[TBL] [Abstract][Full Text] [Related]
13. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts.
Perez C; Jukica A; Listopad JJ; Anders K; Kühl AA; Loddenkemper C; Blankenstein T; Charo J
Int J Cancer; 2015 Jul; 137(2):359-71. PubMed ID: 25530110
[TBL] [Abstract][Full Text] [Related]
14. Genetic redirection of T cells for cancer therapy.
Westwood JA; Kershaw MH
J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
[TBL] [Abstract][Full Text] [Related]
15. Adoptive T-cell therapy of cancer.
Yee C
Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731
[TBL] [Abstract][Full Text] [Related]
16. Is antigen specificity the key to efficient adoptive T-cell therapy?
Labarriere N; Khammari A; Lang F; Dreno B
Immunotherapy; 2011 Apr; 3(4):495-505. PubMed ID: 21463191
[TBL] [Abstract][Full Text] [Related]
17. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
Schultze JL; Michalak S; Seamon MJ; Dranoff G; Jung K; Daley J; Delgado JC; Gribben JG; Nadler LM
J Clin Invest; 1997 Dec; 100(11):2757-65. PubMed ID: 9389740
[TBL] [Abstract][Full Text] [Related]
18. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
[TBL] [Abstract][Full Text] [Related]
20. Rational combinations of in vivo cancer antigen priming and adoptive T-cell therapy mobilize immune and clinical responses in terminal cancers.
Ruan QZ; Fu JQ; Wu XX; Huang LP; Ruan RS
Cancer Immunol Immunother; 2018 Jun; 67(6):907-915. PubMed ID: 29511794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
